Filing Pursuant to Rule 424(b)(2)
Registration Statement No. 333-81263
PROSPECTUS SUPPLEMENT
(TO PROSPECTUS DATED DECEMBER 22, 1999)
152,149 Shares
KOMAG, INCORPORATED
COMMON STOCK
---------------------------
You should read this prospectus supplement and the accompanying
prospectus carefully before you invest. Both documents contain information you
should consider when making your investment decision.
See "Risk Factors" beginning on page 2 of the accompanying prospectus
to read about factors you should consider before buying shares of the
common stock.
PLAN OF DISTRIBUTION
We are offering 152,149 shares of our common stock to one institutional
investor pursuant to this prospectus supplement. The shares of common stock will
be sold at a negotiated purchase price of $3.4688 per share. The $3.4688
purchase price reflects the recent volume weighted average price of our common
stock on the Nasdaq National Market System, net of a discount of 7.5%. We will
not pay commissions or any other compensation in conjunction with this sale of
our common stock.
USE OF PROCEEDS
The net proceeds to us from this offering will be $527,778. We plan to
use the net proceeds for general corporate purposes, including:
- repaying our obligations as they become due;
- financing capital expenditures; and
- working capital
Pending use of the net proceeds for any of these purposes, we may
invest the net proceeds in short-term investment grade instruments,
interest-bearing bank accounts, certificates of deposit, money market
securities, U.S. government securities or mortgage-backed securities guaranteed
by federal agencies.
S-1
<PAGE>
MARKET FOR OUR COMMON STOCK
On April 14, 2000, the last reported sales price of our common shares
on the Nasdaq National Market System was $2.9375 per share. Our common stock is
listed on the Nasdaq National Market under the symbol "KMAG". The common stock
sold under this prospectus supplement will be listed on the Nasdaq National
Market after we notify Nasdaq that the shares have been issued.
As of January 13, 2000, and before the issuance of shares pursuant to
this prospectus supplement, we have 65,874,918 shares of common stock
outstanding.
GENERAL
You should rely only on the information provided or incorporated by
reference in this prospectus supplement and the accompanying prospectus. We have
not authorized anyone else to provide you with different information. You should
not assume that the information in this prospectus supplement is accurate as of
any date other than the date on the front of these documents.
---------------------------
Neither the Securities and Exchange Commission nor any other regulatory
body has approved or disapproved of these securities or passed upon the
accuracy or adequacy of this prospectus. Any representation to the
contrary is a criminal offense.
---------------------------
The date of this prospectus supplement is April 17, 2000.
S-2
<PAGE>
TABLE OF CONTENTS
Page
----
PROSPECTUS SUPPLEMENT
Plan of Distribution..........................................S-1
Use of Proceeds...............................................S-1
Market for Our Common Stock...................................S-2
General.......................................................S-2
PROSPECTUS
Where You Can Find More Information...........................2
The Company...................................................3
Use of Proceeds...............................................4
Ratio of Earnings to Fixed Charges............................4
The Securities................................................4
Description of Debt Securities................................5
Description of Preferred Stock................................6
Description of Depositary Shares..............................7
Description of Warrants.......................................8
Plan of Distribution..........................................9
Legal Matters.................................................11
Experts.......................................................11
S-3
